Carmela Ricciardelli

ORCID: 0000-0001-7415-1854 · 6 papers in corpus
other 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.1015708

The Traditional Chinese medicine, Guizhi Fuling (here called Fuling), has been confirmed in meta-analysis studies to reduce recurrence of endometriosis and improve pregnancy outcomes; however, the possible use of Fuling as a fertility-prese…

2022
Cancers ·doi:10.3390/cancers14102362

The five-year survival rate for women with ovarian cancer is very poor despite radical cytoreductive surgery and chemotherapy. Although most patients initially respond to platinum-based chemotherapy, the majority experience recurrence and u…

2021
Cells ·doi:10.3390/cells10020215

Aquaporins are membrane channels in the broad family of major intrinsic proteins (MIPs), with 13 classes showing tissue-specific distributions in humans. As key physiological modulators of water and solute homeostasis, mutations, and dysfun…

2020
International journal of molecular sciences ·doi:10.3390/ijms22010071

Follicle-stimulating hormone (FSH) and luteinising hormone (LH) play important roles in regulating cell growth and proliferation in the ovary. However, few studies have explored the expression of FSH and LH receptors (FSHR and LHCGR) in ova…

2011
International journal of molecular sciences ·doi:10.3390/ijms12010410

Most scientific efforts towards early detection of ovarian cancer are commonly focused on the discovery of tumour-associated antigens (TAA). Autologous antibodies against TAA, however, may serve as more sensitive diagnostic markers. They ci…

review 2009
Maturitas ·doi:10.1016/j.maturitas.2009.01.001

The origin of epithelial ovarian cancer remains unknown. It is believed to develop from ovarian surface epithelium, post-ovulatory inclusion cysts, endometriosis and more recently the fimbrial end of the fallopian tube. Molecular evidence s…